Impax Asset Management Group PLC Gilead Sciences, Inc. Transaction History

Impax Asset Management Group PLC

$14.9 Billion
Q1 2025

A detailed history of Impax Asset Management Group PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Impax Asset Management Group PLC holds 284,006 shares of GILD stock, worth $31.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

284,006

Previous 380,570 25.37%

Holding current value

$31.4 Million

Previous $35.2 Million 9.48%

% of portfolio

0.21%

Previous 0.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$89.14 - $117.41 $8.61 Million - $11.3 Million	-96,564 Reduced 25.37%	284,006 $31.8 Million
Q4 2024 Feb 04, 2025	BUY	$83.95 - $97.9 $17.9 Million - $20.8 Million	212,828 Added 126.88%	380,570 $35.2 Million
Q3 2024 Oct 30, 2024	SELL	$66.59 - $83.99 $531,321 - $670,156	-7,979 Reduced 4.54%	167,742 $14.1 Million
Q2 2024 Nov 08, 2024	BUY	$63.15 - $72.88 $503,873 - $581,509	7,979 Added 4.76%	175,721 $12.1 Million
Q2 2024 Aug 05, 2024	BUY	$63.15 - $72.88 $3.15 Million - $3.64 Million	49,920 Added 39.68%	175,721 $12.1 Million
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $2.67 Million - $3.25 Million	-37,289 Reduced 22.86%	125,801 $9.21 Million
Q4 2023 Jan 26, 2024	SELL	$73.27 - $83.09 $23,959 - $27,170	-327 Reduced 0.2%	163,090 $13.2 Million
Q3 2023 Nov 07, 2023	BUY	$73.94 - $80.67 $3.97 Million - $4.33 Million	53,704 Added 48.95%	163,417 $12.2 Million
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $50,774 - $57,915	668 Added 0.61%	109,713 $8.46 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $5.38 Million - $6.12 Million	69,533 Added 175.98%	109,045 $9.05 Million
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $124 - $178	2 Added 0.01%	39,512 $3.39 Million
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $52,811 - $60,324	-887 Reduced 2.2%	39,510 $2.44 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $233,592 - $263,095	-4,047 Reduced 9.11%	40,397 $2.5 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $172,949 - $216,723	2,986 Added 7.2%	44,444 $2.64 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $81,554 - $92,565	1,257 Added 3.13%	41,458 $3.01 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $10,085 - $10,881	149 Added 0.37%	40,201 $2.81 Million
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $1,078 - $1,178	-17 Reduced 0.04%	40,052 $2.76 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $119,760 - $136,646	1,996 Added 5.24%	40,069 $2.59 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $180,656 - $205,849	3,189 Added 9.14%	38,073 $2.22 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $66,260 - $83,311	1,067 Added 3.16%	34,884 $2.2 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $63,225 - $73,416	874 Added 2.65%	33,817 $2.6 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $335,759 - $430,059	5,361 Added 19.44%	32,943 $2.46 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $1.7 Million - $1.87 Million	27,582 New	27,582 $1.79 Million

Others Institutions Holding GILD

# of Institutions

2,287

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $138B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account

Impax Asset Management Group PLC Gilead Sciences, Inc. Transaction History